BiH Oncology Patients Face Medication Shortages, Self-Funding Therapies

Oncology patients in Bosnia and Herzegovina are forced to purchase their own medications and often receive only half of prescribed therapies due to chronic underfunding in the public healthcare system. The government's efforts to improve care have not resolved resource gaps, leaving patients to bear costs. This highlights systemic healthcare fragility in a post-conflict state, with implications for public health and social stability.